Francesca Colapietro retweeted
I was walking in Barcelona to my hospital and saw a fantastic young crow attending the EASL School on interpretation of liver biopsy for hepatologists.
Thanks to Xavi Forns and Alba Diaz for organizing it !!
#barcelonaeasl #livertwitter @EASLedu @EASLnews
Francesca Colapietro retweeted
1/🚀JHEP Journal Club🚀
🤔What factors determine the risk of HCC in👫with autoimmune hepatitis (AIH)❓
🔓pubmed.ncbi.nlm.nih.gov/3780…
AIH
👉rare chronic liver disease
👉unclear etiology
@analleo & the Int AIH Group🔍 1428 🌍patients 👇👇👇
#livertwitter
Francesca Colapietro retweeted
🚀 The mission of @ERN_RARE_LIVER is to improve the care of rare liver disease patients throughout Europe.
🎗️ To support Rare Disease Day we also share the stories of our patients, such as our #ERNYouthPanel Series on YouTube:
lnkd.in/eMNw56sK
🔗 rare-liver.eu
❗ 60 Days Until Rare Disease Day ❗
Living with a rare disease often means facing daily uncertainties and embracing resilience in the face of adversity.
Let's come together in these next 60 days, and shine a light on their experiences.
#RareDiseaseDay #ShareYourColours
Francesca Colapietro retweeted
🆕Article in press❕
Incidence and predictors of #hepatocellularcarcinoma in patients with #autoimmunehepatitis
Read it here👉bit.ly/46JfrlY
#LiverTwitter
Francesca Colapietro retweeted
📣Check out our new paper on @AGA_CGH about potential role of #chatGPT 💬 as counselling tool for #NAFLD/#MASLD patients! 🎯
@AghemoAlessio @GiadaSebastiani @VWSWong @schattenbergJ @mromerogomez @lucavalenti75 @salvatore_petta @penny_manousou @lmiele74
cghjournal.org/article/S1542…
Grazie ad AISF per l’opportunità di presentare questi dati, frutto dell’impegno dei colleghi membri dell’ IAIHG, che ringrazio ancora e sempre
Qual è il rischio, per i pazienti affetti da epatite autoimmune, di sviluppare epatocarcinoma? Ce ne ha parlato la dott.ssa Francesca Colapietro, Humanitas University, Milano, in occasione del 55° Congresso AISF... buff.ly/40ES8Hm
Francesca Colapietro retweeted
📢HEAL study❗️
Weekly #albumin infusion in individuals with #cirrhosis improved
✅quality of life
✅endothelial dysfunction
✅inflammation
➡️albumin levels & cognitive benefit persisted after ending infusions
Read it here👉https://nitter.gq/t.co/drUDjePVRf
@JasmohanBajaj
#LiverTwitter
Francesca Colapietro retweeted
Replying to @AlessioGerussi
@AlessioGerussi giving a practical lecture of #DILI in #Immunotherapy at annual meeting... "to biopsy or to treat" @AisfFegato #HCC #LiverTwitter – at Deruta, Umbria
Francesca Colapietro retweeted
📢HEAL study❗️
Weekly #albumin infusion in individuals with #cirrhosis improved
✅quality of life
✅endothelial dysfunction
✅inflammation
➡️albumin levels & cognitive benefit persisted after ending infusions
Read it here👉https://nitter.gq/t.co/drUDjePVRf
@JasmohanBajaj
#LiverTwitter
Francesca Colapietro retweeted
🆕Article in press❕
#HepatocellularCarcinoma risk in patients with chronic #hepatitisB receiving #tenofovir-🆚 #entecavir-based regimens: Individual patient data meta-analysis
🔓#OpenAccess at👉https://nitter.gq/t.co/zghI5CpM1T
#LiverTwitter
Francesca Colapietro retweeted
🆕EXPERT OPINION
Treatment of #portalhypertension in patients with #HCC at the era of #Baveno VII
By Dominique Thabut & Masatoshi Kudo
Read it here👉https://nitter.gq/t.co/djNoEirVsi
@BrainLIverPS
@BavenoVII
#LiverTwitter
Francesca Colapietro retweeted
📢Don't miss our next Webinar❗️
✅The new EASL Clinical Practice Guidelines on sclerosing cholangitis
📅29 November 2022, 18:00 CET
Register here: https://nitter.gq/t.co/UwxSgBjnoO
#LiverTwitter #MedTwitter #ERNRARELIVER #sharecarecure #sharingexpertise
Francesca Colapietro retweeted
🟪NEW Article in press❕
Long-term results of #MycophenolateMofetil 🆚 #azathioprine use in patients with #AutoimmuneHepatitis
🔓#OpenAccess at👉https://nitter.gq/t.co/8ifziCtbQa
#LiverTwitter
Francesca Colapietro retweeted
What does the future hold for #PBC therapies?
Find out today with #EASLStudio!
🔗 easl.eu/easl-studio-episode/…
#Livertwitter #PBCDay2022
@EASLEdu @EASLEUaffairs @GSK @IpsenGroup @CymaBay @AutoimmuneLiver @AnaLleo @PBCFoundation @PBCRobert @PBCers @GlobalLiver
Francesca Colapietro retweeted
🟪NEW Article in press❕
Quantitative magnetic resonance #cholangiopancreatography metrics are associated with disease severity and outcomes in patients with #PrimarySclerosingCholangitis
🔓#OpenAccess at👉https://nitter.gq/t.co/GpbPoqNBWg
#LiverTwitter
Francesca Colapietro retweeted
🔥FDA approves durvalumab for locally advanced or metastatic biliary tract cancer🔥
👉great news for our patients👏👏
👉waiting for EMA... again ....
@myESMO @EASLedu @OncoAlert #livertwitter #cholangiocarcinoma @CcaEns #Immunotherapy
Francesca Colapietro retweeted
I wish to congratulate @Alexfornergon @AghemoAlessio and @lucavalenti75 with the new (and substantially higher) impact factor of @LiverInt 8.754 ✅ This team makes a difference for the #livertwitter field 🙏 for the great work @wileyhealth 👉 Congratulations @ReibergerThomas
Proud to share data📊 on our latest study on incidence and predictors of HCC in a large and multicentric AIH cohort! #ILC2022
Very ⬇️ risk of #HCC development in #AIH 🔴⬆️ risk in >40yo, obese, cirrhotic or AIH-PSC patients 🔴 My colleague and friend @F__Colapietro at #ILC2022 @HumanitasMilano @HUNIMED @EASLnews































